Notably, TGF-β orchestrates CML cellular destiny through a complex PI3K/AKT/NF-κB/MMP9 pathway, which includes NF-κB [83]. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.